On 13 JUNE Nokia Corporation (ADR) (NYSE:NOK) reported $0.03 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.04 by $0.01. The company had revenue of $2.66 billion for the quarter. During the same quarter last year, the company posted ($0.02) earnings per share. Nokia Co.’s revenue was down 54.5% compared to the same quarter last year. Analysts expect that Nokia Co. will post $0.31 EPS for the current fiscal year. Nokia Corporation (ADR) (NYSE:NOK) net profit margin is -9.40% and weekly performance is 2.65%. On last trading day company shares ended up $7.75. Analysts mean target price for the company is $8.23. Nokia Corporation (ADR) (NYSE:NOK) distance from 50-day simple moving average (SMA50) is 8.48%.
On 19 JUNE Lannett Company, Inc. (NYSE:LCI) reported $0.63 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.60 by $0.03. The company had revenue of $80.00 million for the quarter, compared to the consensus estimate of $84.50 million. During the same quarter in the prior year, the company posted $0.14 earnings per share. The company’s quarterly revenue was up 105.0% on a year-over-year basis. Analysts expect that Lannett Company will post $1.75 EPS for the current fiscal year. Lannett Company, Inc. (NYSE:LCI) shares advanced 4.93% in last trading session and ended the day on $49.76. LCI Gross Margin is 48.70% and its return on assets is 13.50%. Lannett Company, Inc. (NYSE:LCI) quarterly performance is 22.14%.
On 17 JUNE Pernix Therapeutics Holdings Inc (NASDAQ:PTX) reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.21. The company had revenue of $19.10 million for the quarter, compared to the consensus estimate of $23.65 million. On average, analysts predict that Pernix Therapeutics Holdings will post $-0.18 earnings per share for the current fiscal year. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares moved up 3.35% in last trading session and was closed at $8.63, while trading in range of $8.28 – $8.69. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) year to date (YTD) performance is 242.46%.
On 16 JUNE Supernus Pharmaceuticals Inc (NASDAQ:SUPN) said it will be entitled to royalties on net sales for the PAH drug, and it may also qualify for other milestone payment in the future. The drug uses Supernus patented technology with the company expressing its pleasure of having played a key role in helping to bring the drug to patients. Supernus Pharmaceuticals Inc (NASDAQ:SUPN) ended the last trading day at $10.72. Company weekly volatility is calculated as 4.28% and price to cash ratio as 7.65. Supernus Pharmaceuticals Inc (NASDAQ:SUPN) showed a positive weekly performance of 4.79%.
On 18 JUNE Versartis Inc (NASDAQ:VSAR) reported ($2.57) earnings per share for the quarter, beating the analysts’ consensus estimate of ($6.37) by $3.80. Analysts expect that Versartis will post $-11.18 EPS for the current fiscal year. Versartis Inc (NASDAQ:VSAR) weekly performance is -12.50%. On last trading day company shares ended up $29.75. Analysts mean target price for the company is $210.27. Versartis Inc (NASDAQ:VSAR) distance from 50-day simple moving average (SMA50) is 3.21%.